BPC 157 is a stable gastric pentadecapeptide BPC 157 discovered in human gastric juice
The supernatants were transferred to clean tubes, then held on ice until the end of the experiment, and stored at 4C afterward until further processing
The overexpression of PGC-1 adeno-associated virus in the brain region of APP23 model mice was observed to result in increased transcription of growth factors, reduced levels of BACE1, and diminished A-mediated neuroinflammation, which collectively led to reduced -amyloid production and neuronal loss (Katsouri et al., 2016)
Yes BPC-157 is frequently studied in combination with TB-500, and is available as part of multi-peptide blends (GLOW, KLOW)
What this means for current drop users Users currently taking compounded oral tirzepatide drops should recognize that the products they use today are essentially placeholder versions of what pharmaceutical companies are working to develop properly